0.80

1.39% -0.0113

After Hours: .79 -0.01 -1.25%

Outset Medical Inc (OM)

Overview News Price History Option Chain Financials Why OM Down? Discussions Forecast

Outset Medical Inc stock is traded at $0.80, with a volume of 371.61K. It is down -1.39% in the last 24 hours and down -37.01% over the past month. Outset Medical Inc is a medical technology company. It has developed a machine, Tablo, which reduces the cost and complexity of dialysis. Tablo provides Renal Replacement Therapy in Hospitals, Chronic Care in Dialysis Clinics and Home Dialysis.

Previous Close:

$0.8113

Open:

$0.82

24h Volume:

371.61K

Relative Volume:

0.35

Market Cap:

$42.96M

Revenue:

$114.73M

Net Income/Loss:

$-140.94M

P/E Ratio:

-0.2899

EPS:

-2.76

Net Cash Flow:

$-126.18M

1W Performance:

-1.48%

1M Performance:

-37.01%

6M Performance:

-77.27%

1Y Performance:

-75.23%

1-Day Range:

$0.782

$0.82

1-Week Range:

$0.75

$0.842

52-Week Range:

$0.435

$5.22

Outset Medical Inc Stock (OM) Company Profile

Name

Outset Medical Inc

Sector

Healthcare (1177)

Industry

Medical Devices (159)

Phone

669-231-8200

Address

3052 ORCHARD DRIVE, SAN JOSE

Employee

480

Twitter

Next Earnings Date

2024-11-06

Latest SEC Filings

OM's Discussions on Twitter

Compare OM with other stocks

Stocks	Price	Market Cap	Revenue	Net Income	Cash Flow	EPS
OM Outset Medical Inc	0.80	42.96M	114.73M	-140.94M	-126.18M	-2.76
ABT Abbott Laboratories	128.22	222.39B	41.95B	13.40B	6.49B	7.65
BSX Boston Scientific Corp	105.02	154.78B	15.91B	1.79B	1.89B	1.21
SYK Stryker Corp	396.07	150.99B	22.60B	2.99B	3.49B	7.76
MDT Medtronic Plc	90.82	116.46B	33.00B	4.29B	5.50B	3.27
EW Edwards Lifesciences Corp	70.99	41.87B	6.60B	4.16B	490.10M	6.93

Outset Medical Inc Stock (OM) Upgrades & Downgrades

Date	Action	Analyst	Rating Change
Aug-08-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Jun-21-24	Upgrade	RBC Capital Mkts	Sector Perform → Outperform
Apr-08-24	Initiated	BTIG Research	Buy
Apr-05-24	Upgrade	CL King	Neutral → Buy
Jan-12-24	Downgrade	RBC Capital Mkts	Outperform → Sector Perform
Oct-13-23	Downgrade	BofA Securities	Buy → Underperform
Aug-17-23	Initiated	CL King	Neutral
Nov-11-22	Initiated	RBC Capital Mkts	Outperform
Jul-14-22	Downgrade	Morgan Stanley	Overweight → Equal-Weight
Mar-02-22	Resumed	BofA Securities	Buy
Feb-17-22	Upgrade	Morgan Stanley	Equal-Weight → Overweight
Aug-18-21	Initiated	Cowen	Outperform
Apr-19-21	Initiated	Wells Fargo	Overweight
Dec-16-20	Initiated	Oppenheimer	Perform
Oct-12-20	Initiated	Barclays	Overweight
Oct-12-20	Initiated	BofA Securities	Buy
Oct-12-20	Initiated	Goldman	Buy
Oct-12-20	Initiated	Morgan Stanley	Equal-Weight
Oct-12-20	Initiated	SVB Leerink	Mkt Perform
Oct-12-20	Initiated	Stifel	Buy

View All

Outset Medical Inc Stock (OM) Latest News

Feb 06, 2025

Kuehn Law Encourages Investors of Outset Medical, Inc. to Contact Law Firm - GlobeNewswire Inc.

Feb 06, 2025

Feb 03, 2025

Outset Medical to Report Fourth Quarter and Full-Year 2024 Financial Results on Wednesday, February 19, 2025 - The Manila Times

Feb 03, 2025

Outset Medical Q4 Earnings: Key Financial Updates Coming as Dialysis Tech Leader Reports - StockTitan

Feb 03, 2025

Feb 02, 2025

OM INVESTOR ALERT: Bronstein, Gewirtz and Grossman, LLC Announces that Outset Medical, Inc. Investors with Substantial Losses Have Opportunity to Lead Class Action Lawsuit! - ACCESS Newswire

Feb 02, 2025

Feb 01, 2025